Cefotetan and beta-lactamases. II. An unusual property: the inactivation of some beta-lactamases by cefotetan

J Antimicrob Chemother. 1983 Jan:11 Suppl:153-7. doi: 10.1093/jac/11.suppl_a.153.

Abstract

Initially, cefotetan interacts with beta-lactamases to form a classical Michaelis complex characterized by a term Ki (the inhibition constant). In a second phase, this complex develops with time to form a new entity devoid of enzymic activity. This new entity may have the structure of an acyl enzyme with variable stability. In the case of TEM-1 and TEM-2 beta-lactamases, the process is progressively and totally reversible. The same phenomena were observed in varying degrees for Pitton's type 2 (PIT-2) penicillinase, OXA-1 and CARB-1. The Klebsiella oxytoca and Proteus vulgaris beta-lactamases are also inactivated by this same process. However, four other cephalosporinases appear to be unaffected by this mechanism.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Cefotetan
  • Cephalosporins / pharmacology*
  • Cephamycins / pharmacology*
  • Hydrogen-Ion Concentration
  • Kinetics
  • beta-Lactamase Inhibitors*

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Cephamycins
  • beta-Lactamase Inhibitors
  • Cefotetan